EGFR and glioblastoma: However, glioblastoma is genetically a highly heterogeneous cancer, and several targets have been implicated in chemoresistance, including MGMT [25,26,27], isocitrate dehydrogenase (IDH) 1/2 [28], and epidermal growth factor receptor [29].